Medical Specialties Patient Care Medical Research Cell Biology Genetics Oncology Medical Workforce Reproductive Rights Cell Biology Diseases and Disorders
It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.